Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Divis advances after USFDA closes out warning letter issued to the company

10-Nov2017

Divis advances after USFDA closes out warning letter issued to the company

Divis Laboratories is currently trading at Rs. 1041.50, up by 31.75 points or 3.14% from its previous closing of Rs. 1009.75 on the BSE.

The scrip opened at Rs. 1025.00 and has touched a high and low of Rs. 1089.90 and Rs. 1025.00 respectively. So far 96,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1319.00 on 10-Nov-2016 and a 52 week low of Rs. 533.10 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 1089.90 and Rs. 992.55 respectively. The current market cap of the company is Rs. 27,652.00 crore.

The promoters holding in the company stood at 52.07%, while Institutions and Non-Institutions held 32.45% and 15.48% respectively.

The US Food and Drug Administration (USFDA) has completed evaluation of Divis Laboratories corrective actions in response to its Warning Letter dated April 13, 2017. The agency has closed-out the warning letter.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry



Related News

View all news

SBI Life shines on reporting 15% rise in Q3 net profit

SBI Life Insurance Company is currently trading at Rs. 635.45, up by 15.65 points or 2.53% from its previous closing of Rs. 619.80 on the BSE.The scrip opened at Rs. 621.00 and has touched a high and low......

Reliance Industries zooms on the bourses

Reliance Industries is currently trading at Rs. 1219.00, up by 36.05 points or 3.05% from its previous closing of Rs. 1182.95 on the BSE.The scrip opened at Rs. 1193.90 and has touched a high and low of......

Infosys surges on the BSE

Infosys is currently trading at Rs. 746.30, up by 15.30 points or 2.09% from its previous closing of Rs. 731.00 on the BSE.The scrip opened at Rs. 733.00 and has touched a high and low of Rs. 750.70 and......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......